Elisabeth Letellier
University of Paris
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Elisabeth Letellier.
Revue de Médecine Interne | 2006
Lionel Carbillon; M. Uzan; A. Kettaneh; Elisabeth Letellier; J. Stirnemann; Nicolas Perrot; A. Tigaizin; Olivier Fain
INTRODUCTIONnWomen with persistently high resistance in uterine arteries have an increased risk of the subsequent development of preeclampsia. Doppler investigation provides a non-invasive method for the study of the uteroplacental blood flow. In pregnant women the antiphospholipid syndrome is associated to an increased risk of preeclampsia and complications related to uteroplacental insufficiency, and the role of uterine artery Doppler is discussed.nnnCURRENT KNOWLEDGE AND KEY POINTSnIn normal pregnancy, impedance to flow in the uterine arteries decreases with gestation, as the likely consequence of the physiologic change of spiral arteries into low-resistance vessels. In women with preeclampsia or related complications, the abnormal persistence of high resistance to flow in the uterine arteries correlates with maternal and neonatal outcome. In one study including patients with antiphospholipid syndrome, a high resistance index in the uterine arteries at 22-24 weeks gestation strongly predicted the subsequent development of preeclampsia. In another study including patients with lupus anticoagulant, persistent bilateral notches at 22-24 weeks gestation may identify preeclampsia and fetal growth restriction with a high sensitivity, specificity, positive and negative predictive value. The treatment may improve the uteroplacental blood flow and is a possible confounding factor which needs further evaluation. FUTURE PROSPECTS AND PROJECTS; In patients with antiphospholipid antibodies a higher impedance has been observed in the uterine artery, suggesting a possible vascular dysfunction precluding to impaired trophoblastic invasion and placental thrombosis, as probable mechanisms in the complications. If confirmed, these findings might have important implications for the management of these patients.
Revue de Médecine Interne | 2006
Lionel Carbillon; M. Uzan; A. Kettaneh; Elisabeth Letellier; J. Stirnemann; Nicolas Perrot; A. Tigaizin; Olivier Fain
INTRODUCTIONnWomen with persistently high resistance in uterine arteries have an increased risk of the subsequent development of preeclampsia. Doppler investigation provides a non-invasive method for the study of the uteroplacental blood flow. In pregnant women the antiphospholipid syndrome is associated to an increased risk of preeclampsia and complications related to uteroplacental insufficiency, and the role of uterine artery Doppler is discussed.nnnCURRENT KNOWLEDGE AND KEY POINTSnIn normal pregnancy, impedance to flow in the uterine arteries decreases with gestation, as the likely consequence of the physiologic change of spiral arteries into low-resistance vessels. In women with preeclampsia or related complications, the abnormal persistence of high resistance to flow in the uterine arteries correlates with maternal and neonatal outcome. In one study including patients with antiphospholipid syndrome, a high resistance index in the uterine arteries at 22-24 weeks gestation strongly predicted the subsequent development of preeclampsia. In another study including patients with lupus anticoagulant, persistent bilateral notches at 22-24 weeks gestation may identify preeclampsia and fetal growth restriction with a high sensitivity, specificity, positive and negative predictive value. The treatment may improve the uteroplacental blood flow and is a possible confounding factor which needs further evaluation. FUTURE PROSPECTS AND PROJECTS; In patients with antiphospholipid antibodies a higher impedance has been observed in the uterine artery, suggesting a possible vascular dysfunction precluding to impaired trophoblastic invasion and placental thrombosis, as probable mechanisms in the complications. If confirmed, these findings might have important implications for the management of these patients.
Revue de Médecine Interne | 2008
Albanne Branellec; M. Thomas; Olivier Fain; Adrien Kettaneh; J. Stirnemann; Elisabeth Letellier
Revue de Médecine Interne | 2006
J. Stirnemann; Louis Brinquin; Elisabeth Letellier; N. Aras; S. Rouaghe; Gabriella Flexor; Marc Borne; Olivier Fain
Revue de Médecine Interne | 2006
Lionel Carbillon; Michele Uzan; Adrien Kettaneh; Elisabeth Letellier; J. Stirnemann; Nicolas Perrot; A. Tigaizin; Olivier Fain
Revue de Médecine Interne | 2006
A. Branellec; Elisabeth Letellier; J. Stirnemann; S. Rouaghe
Revue de Médecine Interne | 2006
J. Stirnemann; Sophie Prevot; Elisabeth Letellier; S. Rouaghe; L. Boukari; Thorsten Braun; A. Kettaneh; Olivier Fain
Revue de Médecine Interne | 2005
Thorsten Braun; J. Stirnemann; F. Caux; A. Kettaneh; Elisabeth Letellier; Olivier Fain; M. Thomas
Journal of Cerebral Blood Flow and Metabolism | 2005
Jérôme Y Couturier; Elisabeth Letellier; Bruno Palmier; Michel Plotkine; Isabelle Margaill
Revue de Médecine Interne | 2001
Elisabeth Letellier; J. Cunningham; R.M. Feakins; G. R. V. Hughes; D P D'Cruz